Amgen and Freeslate, Inc., a provider of high throughput research solutions, have entered into a collaboration to leverage Freeslate solutions in addressing aggregation and particulation in protein drug products. The multi-year project will utilize a range of Freeslate products and services, including technology development, high throughput microscale workflows, and Freeslate’s Lab Execution and Analysis (LEA) software. “As illustrated by this relationship and others we have engaged in over the...